SEC filing · 8-K

Atrium Therapeutics, Inc.: Material agreement

Atrium Therapeutics agreed to raise approximately $50 million through a private placement of common stock and pre-funded warrants.

Filed October 8, 2026

Positive for the company

What happened

On October 7, 2026, the company entered into a securities purchase agreement with accredited investors.

The full interpretation is in the app

Why it matters, the key numbers from the document and what to watch next: the full interpretation of every report is part of Pro.

Read the full interpretation

Read the original

Filing document on SEC.gov Press release (EX-99.1) All documents of this filing

Back to Atrium Therapeutics, Inc.

Summary generated automatically from the filing text and checked against it: every number above is printed in the document. It describes the filing and is not investment advice. Read the original before relying on it.